| Literature DB >> 25614174 |
Hélène Salvator1, Nizar Mahlaoui2, Emilie Catherinot3, Elisabeth Rivaud3, Benoit Pilmis4, Raphael Borie5, Bruno Crestani5, Colas Tcherakian6, Felipe Suarez7, Bertrand Dunogue8, Marie-Anne Gougerot-Pocidalo9, Margarita Hurtado-Nedelec9, Jean-François Dreyfus10, Isabelle Durieu11, Fanny Fouyssac12, Olivier Hermine7, Olivier Lortholary13, Alain Fischer14, Louis-Jean Couderc6.
Abstract
Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by failure of superoxide production in phagocytic cells. The disease is characterised by recurrent infections and inflammatory events, frequently affecting the lungs. Improvement of life expectancy now allows most patients to reach adulthood. We aimed to describe the pattern of pulmonary manifestations occurring during adulthood in CGD patients. This was a retrospective study of the French national cohort of adult patients (≥16 years old) with CGD. Medical data were obtained for 67 adult patients. Pulmonary manifestations affected two-thirds of adult patients. Their incidence was significantly higher than in childhood (mean annual rate 0.22 versus 0.07, p=0.01). Infectious risk persisted despite anti-infectious prophylaxis. Invasive fungal infections were frequent (0.11 per year per patient) and asymptomatic in 37% of the cases. They often required lung biopsy for diagnosis (10 out of 30). Noninfectious respiratory events concerned 28% of adult patients, frequently associated with a concomitant fungal infection (40%). They were more frequent in patients with the X-linked form of CGD. Immune-modulator therapies were required in most cases (70%). Respiratory manifestations are major complications of CGD in adulthood. Noninfectious pulmonary manifestations are as deleterious as infectious pneumonia. A specific respiratory monitoring is necessary.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25614174 DOI: 10.1183/09031936.00118414
Source DB: PubMed Journal: Eur Respir J ISSN: 0903-1936 Impact factor: 16.671